|Day Low/High||90.01 / 96.13|
|52 Wk Low/High||37.36 / 97.27|
MADISON, Wis., March 5, 2019 /PRNewswire/ -- Exact Sciences Corporation (NASDAQ: EXAS) (the "Company") today announced an underwritten public offering of $600 million aggregate principal amount of convertible senior notes due 2027 (the "Notes") pursuant...
MADISON, Wis., March 1, 2019 /PRNewswire/ -- Exact Sciences Corp.
Exact Sciences Announces Milestone Ahead of Cologuard Classic, National Colorectal Cancer Awareness Month
- Fourth quarter revenue increased 64 percent to $143.0 million
Jim Cramer's plan for getting through the heart of earnings season next week.
Jim Cramer weighs in on Cronos, Fortinet, Dominion Energy and more.
- Cologuard test volume increased 64 percent, with approximately 934,000 tests completed in 2018
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AES, ALIM, APPS, EXAS, INVH, LBRDA, LBRDK, LLY, TLK Downgrades: CTT, DRH, HA, MTDR, ORIT, RNG Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Our strategy on EXAS shares after the company's latest earnings.
Jim Cramer takes a closer look at Costco, Tellurian, Exact Sciences, XPO Logistics, Align Technology and more.
Jim Cramer says investors need to remember how terrific these companies are, and why they can't be written off.
- Demand accelerated from healthcare providers as more than 11,000 ordered their initial Cologuard test during the third quarter, and nearly 132,000 have ordered since the test was launched
Jim Cramer takes a closer look at Raytheon, Northrop Grumman, Zuora, Exact Sciences.
This trillion-dollar level is so meaningful, Jim Cramer says, because Apple may be the first company to get here, but it won't be the last. Get ready.
Technology Promotes High-Quality Results from Liquid Biopsy Cancer Tests
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component EXACT Sciences Corp. was identified as having a larger market cap than the smaller end of the S&P 500, for example Qorvo Inc , according to The Online Investor.
ZTS discovers, develops, manufactures, and markets veterinary vaccines and medicines.
Here are the top healthcare bets ticking all the boxes for analysts.
Nobody likes tariffs, says Jim Cramer. But Trump said he'd do it. Even so, trade and tariff fears have hit Wall Street -- and investors -- hard.
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in EXACT Sciences Corp. , where a total volume of 12,345 contracts has been traded thus far today, a contract volume which is representative of approximately 1.2 million underlying shares (given that every 1 contract represents 100 underlying shares).
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component EXACT Sciences Corp. was identified as having a larger market cap than the smaller end of the S&P 500, for example Tripadvisor Inc , according to The Online Investor.
The stock still looks vulnerable to further declines from a technical perspective.
Kevin Conroy, chairman and CEO of Exact Sciences, tells Jim Cramer about his company's expansion plans for cancer screening tests.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.